Spain provides regulatory scientific advice through AEMPS, while access-facing early dialogue is channelled through the National Health System's evaluation and therapeutic positioning work coordinated with the Autonomous Communities. EU Joint Scientific Consultations add an earlier EU layer that interacts with both national tracks.
